While DBP polymorphisms may be involved in the link between vitamin D status and COVID-19 outcome, many other polymorphisms in Vitamin D metabolic pathway genes might also be involved, and future research should acknowledge investigating vitamin D status in the context of such polymorphism distribution in each study population, and proper vitamin D levels should be estimated taking these polymorphisms into consideration. This evidence concerns the gene DBP and COVID-19.